# FDA recall D-1386-2014

> **Actavis Inc** · Class II · drug recall initiated 2014-05-16.

## Product

Vancomycin Hydrochloride Capsules, USP, 250 mg.  20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

## Reason for recall

Subpotent Drug.

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-1386-2014
- **Recalling firm:** Actavis Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-05-16
- **Report date:** 2014-06-25
- **Termination date:** 2015-02-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1386-2014

## Citation

> AI Analytics. FDA recall D-1386-2014. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1386-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*